ࡱ> EGD@ R6&bjbjFF24,,RRRRRRR\h*****%%%$^R 9R%%%%%RR**"%R*R*%%RR#* @YNMD80h,8!^8!#f$RRRR8!R#\%%K<%%%%%5EBP CASE CONFERENCE 2004t^4g15e [zvhn0 TMR] Clinical case [21MRk0zvhW0f0D00n0g00!|Tok0pn000] Clinical question [S0S0o0B0j0_0L0W00y0_0K0c0_0PECO0fO0a] P: E: C: O: [OL0[o0Nju'YR0WL0Rk0Tn0oD000000n0007_W0f0D00S0h0L0YD0L00vn0MRn0`ik0h0c0f0UOL0Nju'YRK00֊ek0S__00MRk02d0N NcR0f0J0O0S0h0] Literature search Summary of the study [S0n0PECOo0֊ek0j00c0f0~0h0000]0n0o0 Nn0PECO000sW0O00PETCOTk0j00h0`D0~0Y00S0S0g0To0bi00`0Q0n0gn0lBv0W0_00c0 0UO1_UO0g_0UOt^_ n0i0F0D0F0P}gg0]L0Q0K0 0h0f:yW0j0O0f0o0j00j0D00OH0p00] P: ba'`'YF0d0u0~0_0o0lR Yuk0͑suW0_0'YF0d0u0~0_0o000000k0[hQ[㉒04O0j0D0S_'`'YF0d0ug00000000n0HAM-DL020pN N ET: 121n0nefazodone 460 mg/e + CBASP(1k01V01Bf) C: nefazodone 460 mg/e + clinical management OT1: remission=101J00s0121n0HRSDL08pN N OT2: response=101J00s0121n0HRSDL050%N NNO NW0f015pN N Assessed for eligibility (n=) ! ! !!!!!!!! ! !Excluded (n=) Did not meet inclusion criteria (n=) Refused to participate (n=) Other reasons (n=) Randomized (n=) !!AllocationAllocated to intervention (n=)*** Did not receive allocated intervention (n=)* Received some intervention but did not complete (n=)* Completed intervention (n=)* Discontinued interve(02468<p     & . 6 > F V ^ j l x z    ( : d f j l n p   ̽۽ֹֽh0x: h0x:o( hwAo( hu0o( hs,o( h*Qo( h o( h1)o( hbo( h|`o( h8o( hC<o(hC<CJ(OJQJo(F(*RTp   8!zc8!s8!8!s8!8!8!s8!s8!s8!s8!s8!s8!s8!8!8!s8!s8!s8!8!s8!8!s8!s8!s8!s8!s8!s8!s$a$6&  f    F H J L 8!8!8!8!8!8!8!8!sqj"jj>jzi8!jmkd$$Ifc\!764 ca $$Ifa$$Ifgd8L N P T X n r v :qj"j j j j j j j j j j $IfVDd^$If $$4$Ifa$ $$Ifa$$If  P R T V X h n p r t jlpr(*,.""F"P"R"T"""""6#8#:#######&$N$߹߬ߌĀ߹h8hCJaJo(h*Qh8CJaJo(hzRCJOJQJaJo( hzRCJo(h CJOJQJaJo(h CJaJo(UhCJaJo(h8CJaJo(h CJaJo(h8h8CJaJo( h CJo( hC<CJ hC<CJo(2:<>@Bbd 8!jqj"jj>j $$Ifa$$Ifmkd$$Ifc\2!7v R 64 cadfhjnpti8!jqj jXj j $$Ifa$$Ifmkdt$$Ifc\!764 catv,.iy jy jp jg jp jp jp jg j $Ifgd8 $Ifgd*Q$Ifqq$If]q^qrkd5$$Ifc\<!7J J 64 ca ntion but were assessed at endpoint (n=)  *h0*h0*0W0_000***k0j00o0Z00 o0~0_0%Rn0peW[0Allocated to intervention (n=) Did not receive allocated intervention (n=) Received some intervention but did not complete (n=) Completed intervention (n=) Discontinued intervention but were assessed at endpoint (n=)!!AnalysisExcluded from analysis (n=) Analyzed (n=) Excluded from analysis (n=) Analyzed (n=)  Critical Appraisal of the study Internal validity Results External validity What shall I do with THIS patient? T"V"X"Z"\"^"`"b"""""8#:#####Z$ sDXjXjXjXjXjXjXjX CX C j j j j j j j j j $Ifgd $Ifgd8 $Ifgd*Q$If$IfVD^gdN$X$^$`$d$f$|$$$%4%%%0&6&hC<OJQJ^Jo(hC<OJQJ^J hC<o( hCJo( hC<CJ hC<CJo(h8h8CJaJo(Z$\$^$b$d$h$Yqj| jXj| j $$Ifa$$Iftkd$$Ifcn\<! 7J J 64 cah$j$|$$$$$$$%%.%0%iv jp jp jp jv jpXjv jp jp jp j$If $Ifgdqq$If]q^qrkd$$Ifc\<!7J J 64 ca 0%2%4%6%v%%%%%%%%%%% j 8!s~8!|8!R8!s8!s8!s8!s|8!R8!s8!s8!s8!stkd$$Ifcn\<! 7J J 64 ca $Ifgd%%%%%%%%0&2&4&6&8!R8!s8!s8!s8!s8!s8!s8!8!s8!s8!s &dP 0&P 1h. A!"#$%S $$If!vh57555#v7#v#v#v:V c657555/ / / 44 c$$If!vh5755v 5R #v7#v#vv #vR :V c65755v 5R / / 44 c$$If!vh57555#v7#v#v#v:V c657555/ / / 44 c$$If!vh575J 55J #v7#vJ #v#vJ :V c6575J 55J / / 44 c$$If!vh575J 55J #v7#vJ #v#vJ :V cn6)v575J 55J / / / / / 44 c$$If!vh575J 55J #v7#vJ #v#vJ :V c6575J 55J / / 44 c$$If!vh575J 55J #v7#vJ #v#vJ :V cn6)v575J 55J / / / / / 44 cN@N jn 1$G$H$$CJKHOJQJ_HmH nHsH tHJ@J QW0 1&d @&P OJPJQJaJF@F QW0 2&d@&P OJPJQJF@F QW0 3&d@&P OJPJQJ$A$ k=0000Fi@F jnn0h :V 44 la $k$000j0W0 2>@2 hL$a$ CJ OJQJ6C@6 ,ge00000VDd^4 "& "&4)*8QRSTUVWXj3V  !1234578:;Fhi*+,-./01FPop-./1245>Z[ijkl\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0\>0% \>0% \>0% P\>0\>0\>0+ \>0+\>0+\>0+\>0+\>0+ \>0+\>0+\>0+\>0+ ``UV\>0\>0\>08 \>08 \>08 \>00 0 0 0 0 0 000 000000000 000 0 0 0 0 0 0 0 000 0 000 0 00000000000 00000 00000 0 00000  N$6&  L :dtZ$h$0%%6& 6& XC 7""7""@0(  B S  ?!':O/6<HI DHJLPQRUfjlnrsv|~()23456<?EFO',3!FFP,/>'<   %@@,@0^`0o(.H\H^H`\()\^`\\^`\.4\4^4`\() \ ^ `\| \| ^| `\. \ ^ `\()\^`\,Qt         [0r(1)s,0x:C<wA*Q|`b zRu08 !1234578:;F*P-./1245>kl@ ''77''4pp pp"UnknownGz Times New Roman5Symbol3& z Arial9V  BroadwayG h-3 fgMS Mincho7CenturyK5  h-3 0000MS Gothic9V Algerian qHhHIh4Y2 2 !3!%),.:;?]}  0 2 3 !000 0 0 00000000000 =]acde$([\{  0 0 0000;[bnrd3QHX-?8EBP CASE CONFERENCEToshi FurukawaToshi Furukawa Oh+'0 0< X d p |EBP CASE CONFERENCEBP Toshi FurukawaEoshoshebpcaseconference.dot1Toshi Furukawac1shMicrosoft Word 10.0@F#@𵃯6@DM@BhM2՜.+,0$ hp  +DEPT OF PSYCHIATRY, NAGOYA CITY UNIVERSITYN  EBP CASE CONFERENCE Title  !"$%&'()*+,-./012356789:;=>?@ABCFRoot Entry F@fMHData 1Table#H!WordDocument24SummaryInformation(4DocumentSummaryInformation8<CompObjf  FMicrosoft Word MSWordDocWord.Document.89q